These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34989)

  • 1. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.
    Frishman W
    Am Heart J; 1979 May; 97(5):663-70. PubMed ID: 34989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
    Lowenthal DT; Saris SD; Packer J; Haratz A; Conry K
    Am J Med; 1984 Oct; 77(4A):119-27. PubMed ID: 6148890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.
    Frishman WH; Alwarshetty M
    Clin Pharmacokinet; 2002; 41(7):505-16. PubMed ID: 12083978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blockade. An update.
    Frishman WH; Teicher M
    Cardiology; 1985; 72(5-6):280-96. PubMed ID: 2866839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta blockers: the extended family.
    Hager WD; Messineo FC; Katz AM
    Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
    Shand DG
    Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical pharmacology of beta-adrenoceptor blocking drugs and therapeutic use in hypertension (author's transl)].
    Ebihara A
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):297-312. PubMed ID: 6103912
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?
    Szentmiklosi AJ; Szentandrássy N; Hegyi B; Horvath B; Magyar J; Bányász T; Nanasi PP
    Curr Pharm Des; 2015; 21(8):1030-41. PubMed ID: 25354180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic aspects of some beta-adrenoceptor blocking drugs.
    Regårdh CG
    Acta Med Scand Suppl; 1982; 665():49-60. PubMed ID: 6130675
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug.
    Frishman W
    Am Heart J; 1980 Jan; 99(1):124-8. PubMed ID: 6101295
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical pharmacology of beta adrenergic blocking drugs.
    McDevitt DG; Shanks RG; Prichard BN
    J R Coll Physicians Lond; 1976 Oct; 11(1):21-34. PubMed ID: 10437
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic blockers in the prevention of sudden death.
    Frishman WH; Laifer LI; Furberg CD
    Cardiovasc Clin; 1985; 15(3):249-64. PubMed ID: 2421902
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.
    Bodem G; Chidsey CA
    Clin Pharmacol Ther; 1973; 14(1):26-9. PubMed ID: 4405104
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.
    Baker JG; Hill SJ; Summers RJ
    Trends Pharmacol Sci; 2011 Apr; 32(4):227-34. PubMed ID: 21429598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 13. The beta-adrenoceptor blocking drugs: a perspective.
    Frishman W
    Am Heart J; 1980 May; 99(5):665-70. PubMed ID: 6102840
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.